Selective inhibition of P300 HAT activity using C646 small molecule inhibitor has been shown to inhibit cell growth and sensitize cells to DNA damaging agents in other cancers, including melanoma48 NSLC49, colorectal50, prostrate51,52 and neuroblastoma53. This evidence concerns the gene EP300 and cancer.